Statistical Correction for Non‐parallelism in a Urinary Enzyme Immunoassay

References

• O'Fegan , P. 2000 . “ Validation ” . In Immunoassays: A Practical Approach Edited by: Gosling , J. P. 211 – 238 . Oxford : Oxford University Press .
   Google Scholar
• Spencer , C. A. , Platler , B. W. and Nicoloff , J. T. 1985 . The effect of [125I]thyroglobulin tracer heterogeneity on serum Tg RIA measurement . Clin. Chim. Acta , 153 ( 2 ) : 105 – 115 . [PUBMED] [INFOTRIEVE]
   PubMedGoogle Scholar
• Thomas , C. M.G. , van den Berg , R. J. , de Koning Gans , H. J. and Lequin , R. M. 1978 . Radioimmunoassays for prostaglandins. I. Technical validation of prostaglandin F2alpha measurements in human plasma using Sephadex G‐25 gelfiltration . Prostaglandins , 15 ( 5 ) : 839 – 847 . [INFOTRIEVE] [CROSSREF]
   PubMedGoogle Scholar
• McCready , J. , Braunstein , G. D. , Helm , D. and Wade , M. E. 1978 . Modification of the choriogonadotropin beta‐subunit radioimmunoassay for determination of urinary choriogonadotropin . Clin. Chem. , 24 ( 11 ) : 1958 – 1961 . [PUBMED] [INFOTRIEVE]
   PubMedGoogle Scholar
• Linnet , K. 1993 . Effect of the biological matrix on the urinary testosterone/epitestosterone ratio measured by gas chromatography/mass spectrometry in doping analysis . Biol. Mass Spectrom. , 22 ( 7 ) : 412 – 418 . [PUBMED] [INFOTRIEVE] [CSA]
   PubMedGoogle Scholar
• Gilfillan , C. P. and Robertson , D. M. 1994 . Development and validation of a radioimmunoassay for follistatin in human serum . Clin. Endocrinol. , 41 ( 4 ) : 453 – 461 .
   PubMedGoogle Scholar
• Lichtenberg , V. , Pahnke , V. G. , Graesslin , D. and Bettendorf , G. 1982 . Biological and immunological potencies of lutropin (LH) in human serum: comparative studies using different standard preparations . Horm. Metab. Res. , 14 ( 1 ) : 39 – 45 . [PUBMED] [INFOTRIEVE]
   PubMedGoogle Scholar
• Leidenberger , F. A. , Willashek , R. , Pahnke , V. G. and Reichert , L. E. 1976 . Application of a radioligand receptor assay for determination of luteinizing hormone in human serum . Acta Endocrinol. , 81 ( 1 ) : 54 – 72 . [PUBMED] [INFOTRIEVE]
   PubMedGoogle Scholar
• Rajalakshmi , M. , Robertson , D. M. , Choi , S. K. and Diczfalusy , E. 1979 . Biologically active luteinizing hormone (LH) in plasma: validation of the in vitro bioassay when applied to male plasma and the possible role of steroidal precursors . Acta Endocrinol. , 90 ( 4 ) : 585 – 598 . [PUBMED] [INFOTRIEVE]
   PubMedGoogle Scholar
• O'Rorke , A. , Kane , M. M. , Gosling , J. P. , Tallon , D. F. and Fottrell , P. F. 1994 . Development and validation of a monoclonal antibody enzyme immunoassay for measuring progesterone in saliva . Clin. Chem. , 40 ( 3 ) : 454 – 458 . [PUBMED] [INFOTRIEVE] [CSA]
   PubMedGoogle Scholar
• Chard , T. 1995 . An Introduction to Radioimmunoassay and Related Techniques Amsterdam : Elsevier .
   Google Scholar
• Reader , S. C.J. , Daly , J. R. and Robertson , W. R. 1982 . Effect of human plasma on the bioactivity of adrenocorticotrophin . J. Endocrinol. , 92 ( 3 ) : 449 – 455 . [INFOTRIEVE]
   PubMedGoogle Scholar
• Bayer , M. F. and McDougall , I. R. 1984 . Differences in radioimmunoassay results for thyroglobulin that affect management of patients with thyroid cancer . Clin. Chem. , 30 ( 1 ) : 81 – 86 . [INFOTRIEVE]
   PubMedGoogle Scholar
• Andersen , L. , Vølund , A. , Olsen , K. J. , Plum , A. and Walsh , D. 2001 . Validity and use of a non‐parallel insulin assay for pharmacokinetic studies of the rapid‐acting insulin analogue, insulin aspart . J. Immunoassay Immunochem. , 22 ( 2 ) : 147 – 163 . [PUBMED] [INFOTRIEVE] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Ding , Y. Q. and Huhtaniemi , I. 1989 . Human serum LH inhibitor(s): behaviour and contribution to in vitro bioassay of LH using dispersed mouse leydig cells . Acta Endocrinol. , 121 ( 1 ) : 46 – 54 . [PUBMED] [INFOTRIEVE]
   PubMedGoogle Scholar
• Romaní , P. , Robertson , D. M. and Diczfalusy , E. 1976 . Biologically active luteinizing hormone (LH) in plasma: validation of the in vitro bioassay when applied to plasma of women . Acta Endocrinol. , 83 ( 3 ) : 454 – 465 .
   PubMedGoogle Scholar
• Tomada , Y. , Miwa , T. and Ishizuka , N. 1975 . Radioligand receptor assay for urinary and serum hCG . J. Clin. Endocrinol. Metab. , 40 ( 4 ) : 644 – 651 .
   PubMedGoogle Scholar
• Hunter , W. M. and Bennie , J. G. 1979 . Reduction of non‐specific serum responses in human pituitary gonadotrophin radioimmunoassays . J. Endocrinol. , 80 ( 1 ) : 59 – 68 . [PUBMED] [INFOTRIEVE]
   PubMedGoogle Scholar
• Dufau , M. L. , Pock , R. , Neubauer , A. and Catt , K. J. 1976 . In vitro bioassay of LH in human serum: the rat interstitial cell testosterone (RICT) assay . J. Clin. Endocrinol. Metab. , 42 ( 5 ) : 958 – 969 . [PUBMED] [INFOTRIEVE]
   PubMedGoogle Scholar
• Hitzler , W. , Schmidt‐Gayk , H. , Spiropoulos , P. , Raue , F. and Hüfner , M. 1982 . Homologous radioimmunoassay for human parathyrin (residues 53–84) . Clin. Chem. , 28 ( 8 ) : 1749 – 1753 . [PUBMED] [INFOTRIEVE]
   PubMedGoogle Scholar
• Lichtenberg , V. and Pahnke , V. G. 1976 . Measurement of biologically active LH/HCG by in vitro testosterone production assay (TPA) and problems when applied to serum . Acta Endocrinol. Suppl. , 202 : 54 – 57 .
   Google Scholar
• O'Malley , B. W. and Strott , C. A. 1999 . “ Steroid hormones: metabolism and mechanism of action ” . In Reproductive Endocrinology: Physiology, Pathophysiology and Clinical Management Edited by: Yen , S. S.C. , Jaffe , R. B. and Barbieri , R. L. 110 – 133 . Philadelphia : WB Saunders Co. .
   Google Scholar
• Munro , C. J. , Stabenfeldt , G. H. , Cragun , J. R. , Addiego , L. A. , Overstreet , J. W. and Lasley , B. L. 1991 . Relationship of serum estradiol and progesterone concentrations to the excretion profiles of their major urinary metabolites as measured by enzyme immunoassay and radioimmunoassay . Clin. Chem. , 37 ( 6 ) : 838 – 844 . [PUBMED] [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Denari , J. H. , Farinati , Z. , Figueroa Casas , P. R. and Oliva , A. 1981 . Determination of ovarian function using first morning steroid assays . Obstet. Gynecol. , 58 ( 1 ) : 5 – 9 . [PUBMED] [INFOTRIEVE]
   PubMedGoogle Scholar
• Barnard , G. , Kohen , F. , Mikola , H. and Lovgren , T. 1989 . Measurement of estrone‐3‐glucuronide in urine by rapid, homogeneous time‐resolved fluoroimmunoassay . Clin. Chem. , 35 ( 4 ) : 555 – 559 . [PUBMED] [INFOTRIEVE]
   PubMedGoogle Scholar
• O'Connor , K. A. , Brindle , E. , Holman , D. J. , Klein , N. A. , Soules , M. R. , Campbell , K. L. , Kohen , F. , Munro , C. J. , Shofer , J. B. , Lasley , B. L. and Wood , J. W. 2003 . Urinary estrone conjugate and pregnanediol‐3‐glucuronide enzyme immunoassays for population research . Clin. Chem. , 49 ( 7 ) : 1139 – 1148 . [PUBMED] [INFOTRIEVE] [CROSSREF] [CSA]
   PubMed Web of Science ®Google Scholar
• Kohen , F. and Lichter , S. 1986 . “ Monoclonal antibodies to steroid hormones ” . In Monoclonal Antibodies: Basic Principles, Experimental and Clinical Applications in Endocrinology Edited by: Fortie , G. , Lipsett , M. B. and Serio , M. 87 – 95 . New York : Raven Press .
   Google Scholar
• Kesner , J. S. , Knecht , E. A. , Krieg , E. F. , Barnard , G. , Mikola , H. , Kohen , F. , Gani , M. M. and Coley , J. 1994 . Validations of time‐resolved fluoroimmunoassays for urinary estrone‐3‐glucuronide and pregnanediol‐ 3‐glucuronide . Steroids , 59 ( 3 ) : 205 – 211 . [PUBMED] [INFOTRIEVE] [CROSSREF] [CSA]
   PubMed Web of Science ®Google Scholar
• Rodbard , D. 1974 . Statistical quality control and routine data processing for radioimmunoassays and immunoradiometric assays . Clin. Chem. , 20 ( 10 ) : 1255 – 1270 . [PUBMED] [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Alfthan , H. , Bjorses , U. , Tiitinen , A. and Stenman , U. 1993 . Specificity and detection limit of ten pregnancy tests . Scand. J. Clin. Lab. Invest. Suppl. , 216 : 105 – 113 . [PUBMED] [INFOTRIEVE]
   PubMedGoogle Scholar
• Miller , R. C. , Brindle , E. , Holman , D. J. , Shofer , J. B. , Klein , N. A. , Sooles , M. R. and O'Connor , K. A. 2004 . Comparison of specific gravity and creatinine methods for normalizing urinary reproductive hormone concentrations . Clin. Chem. , 50 ( 5 ) : 924 – 932 . [PUBMED] [INFOTRIEVE] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Pinheiro , J. C. and Bates , D. M. 2000 . Mixed‐Effects Models in S and S‐PLUS New York : Springer .
   Google Scholar
• Rodbard , D. 1978 . Statistical estimation of the minimal detectable concentration (“Sensitivity”) for radioligand assays . Anal. Biochem. , 90 ( 1 ) : 1 – 12 . [PUBMED] [INFOTRIEVE] [CROSSREF]
   PubMedGoogle Scholar
• Vonesh , E. F. and Chinchilli , V. M. 1997 . Linear and Nonlinear Models for the Analysis of Repeated Measurements 252 – 253 . New York : Dekker .
   Google Scholar
• Baird , D. D. , McConnaughey , R. , Weinberg , C. R. , Musey , P. I. , Collins , D. C. , Kesner , J. S. , Knecht , E. A. and Wilcox , A. J. 1995 . Application of a method for estimating day of ovulation using urinary estrogen and progesterone metabolites . Epidemiology , 6 ( 5 ) : 547 – 550 . [PUBMED] [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Baker , T. E. , Jennison , K. M. and Kellie , A. E. 1979 . The direct radioimmunoassay of oestrogen glucuronides in human female urine . Biochem. J. , 177 ( 2 ) : 729 – 738 . [PUBMED] [INFOTRIEVE]
   PubMedGoogle Scholar